HOUSE_OVERSIGHT_024656.jpg
1.46 MB
Extraction Summary
0
People
4
Organizations
1
Locations
0
Events
0
Relationships
3
Quotes
Document Information
Type:
Investment report / market research
File Size:
1.46 MB
Summary
This document is page 20 of a Cannabis Investment Report dated December 2017, produced by Ackrell Capital, LLC. It details scientific information regarding cannabinoids, specifically contrasting THC and CBD, and provides a matrix of medical conditions (such as Cancer, ALS, and Glaucoma) alongside the specific cannabinoids used to treat them. The document bears a 'HOUSE_OVERSIGHT_024656' Bates stamp, indicating it was part of a document production for the House Oversight Committee, though the text itself contains no direct references to Jeffrey Epstein or his associates.
Organizations (4)
| Name | Type | Context |
|---|---|---|
| Ackrell Capital, LLC | ||
| FINRA | ||
| SIPC | ||
| House Oversight Committee |
Locations (1)
| Location | Context |
|---|---|
Key Quotes (3)
"Cannabinoids are compounds present in the cannabis plant that act on human cannabinoid receptors in cells in the nervous and immune systems."Source
HOUSE_OVERSIGHT_024656.jpg
Quote #1
"Generally, the most abundant cannabinoid is THC, a psychoactive compound that causes a euphoric 'high,' and the second most abundant cannabinoid is cannabidiol, or CBD, which produces a relaxing physical effect without a psychoactive effect."Source
HOUSE_OVERSIGHT_024656.jpg
Quote #2
"THC is the most abundant cannabinoid in cannabis and is understood to be the psychoactive compound in cannabis primarily responsible for the euphoric feeling of being 'high.'"Source
HOUSE_OVERSIGHT_024656.jpg
Quote #3
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document